We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Microrheological Method Determines Blood Type

By LabMedica International staff writers
Posted on 13 Aug 2013
Print article
Image: Scheme of microfluidic apparatus for blood typing (Graphics courtesy of the Polish Institute of Physical Chemistry).
Image: Scheme of microfluidic apparatus for blood typing (Graphics courtesy of the Polish Institute of Physical Chemistry).
The development of microfluidic blood-typing assays can reduce the time of analysis, and enable simultaneous determination of the most clinically important antigens.

A method for typing and subtyping blood has been developed in a simple microfluidic system that monitors the speed of flow of microdroplets and determining agglutination in small samples of liquid.

Scientists at the Institute of Physical Chemistry of the Polish Academy of Sciences (Warsaw, Poland) have demonstrated a microfluidic method for reproducible and objective determination of agglutination in small, nanoliter quantities of liquid. They demonstrated the reliability of the method on the model example of determination of blood type, yet the method should also be possible to use with the wide range of agglutination assays used in in vitro diagnostics.

The investigators tested agglutination in droplets with A, B and O blood groups, and then a second series of agglutination test in droplets with different Rh factors. Each series was performed for both standardized red blood cells and human blood samples. The red blood cells were not removed from the whole blood before these tests. In each series a droplet with antibodies was linked in the merging chamber with a droplet containing red blood cells. The merging chamber was equipped with two electrodes connected to a source of alternating current (AC) electrostatic potential. An oscillating electric field speeds up the coalescence of droplets arriving from the individual T-junctions. A created droplet was sent to the section of measurement for the time of flow.

The method had a very high sensitivity and reliability. The reliability approached 100% with an estimated chance of mistyping on the order of one per million samples. The method of detection of agglutination could potentially be used for automating various agglutination assays. The authors noted that the method offers the potential benefits of a reduction of the volume of blood sample to single microliters for the whole test, the lack of requirement for preprocessing such as centrifugation, and eliminating any subjectivity from the procedure.

Importantly, the method could be compliant both with a point-of-care format for the simplest blood-typing protocols and with multiplexed assays for complex analyses, such as cross-match testing or other multiple antigen determinations in a bench-top format. The study was published on June 18, 2013, in the journal Lab on a Chip.

Related Links:
Polish Institute of Physical Chemistry

Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
New
Troponin I Test
Quidel Triage Troponin I Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.